From First-in-Human to Real Use: Why MedTech Innovations Stall – Powered by 3PH Alliance/HRCRS

September 19, 2026 | 08:50 AM (EDT) - 09:35 AM (EDT)

Share This event

Speakers
David Krummen
Professor of Clinical Medicine
University of California San Diego
Michael Lesh
Adjunct Professor of Medicine | Founder & CEO
UCSF | Quench, Inc.
Jason Moore
Chief Commercial Officer
3PH Alliance/HRCRS
Joe Sasson
Chief Commercial Officer and EVP, MedAxiom Venture
MedAxiom - An ACC Company
Rebecca Seidel
SVP & President, Cardiac Ablation Solutions
Medtronic
Paul Wang
Director of the Stanford Cardiac Arrhythmia Service & Professor of Medicine and of Bioengineering
Stanford Medicine
Moderator
Babak Nazer
Professor of Medicine and Bioengineering | Cardiac Electrophysiologist
University of Washington

From First-in-Human to Real Use: Why MedTech Innovations Stall

Roundtable 2
September 19, 2026 | 08:50 AM (EDT) - 09:35 AM (EDT)

Many MedTech companies generate clinical data and still fail to gain traction because their evidence does not align with how care is actually delivered, evaluated, and paid for. Health systems, physicians, and administrators are not asking for more data, they are asking for clarity on outcomes, workflow impact, and economic value. This roundtable brings together provider, regulatory, and clinical strategy perspectives to unpack why evidence fails to influence real decisions and what it takes to build a case that drives use in practice.

Powered by 3PH Alliance/HRCRS